Status:
COMPLETED
Within Household Transmission of COVID-19 Infections
Lead Sponsor:
UMC Utrecht
Conditions:
SARS-CoV-2
Eligibility:
All Genders
Brief Summary
In the absence of a vaccine, the spread of SARS-CoV-2 can only be mitigated via non-pharmaceutical interventions that reduce the risks of forward transmission. Currently, European policymakers are imp...
Eligibility Criteria
Inclusion
- All members of the household or their legal guardians consent to participation
- All members of the household are willing to complete diaries and questionnaires for the duration of follow-up
- All members of the household are willing to, and capable of self-sampling nose-throat swabs, (a subset) saliva and capillary blood samples by finger. If parents/caretakers of young children are reluctant to take a blood sample from their child, this is no reason for exclusion.
Exclusion
- Patients or household members who are unable to consent, or do not wish to provide informed consent.
- Children, pregnant women and patients lacking capacity will be included. Those lacking capacity to consent for themselves will be identified and consent will be sought from an appropriate consulted.
- Households who do not have daily access to a smartphone or tablet with internet connection, will be excluded, as follow-up of households requires the use of an interactive diary App.
Key Trial Info
Start Date :
January 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT05430516
Start Date
January 15 2022
End Date
May 1 2022
Last Update
June 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMC Utrecht
Utrecht, Netherlands, 3584CX